An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2.
Future Sci OA
; 7(8): FSO739, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1278250
ABSTRACT
In this retrospective study, a cohort of 67 subjects vaccinated with AZD1222 was retrospectively observed. Consistently with published findings, no serious adverse event was reported, and all adverse events reported (fever, muscle ache and/or pain in the site of injection) had resolved by day 8. Of note, some citizens were prescribed low-dose aspirin and even heparin for thrombosis prevention. We also found variations in laboratory test results (full blood count and chemistry) on day 1 compared with day 8. Physicians should be aware that no prevention therapy for thrombosis is currently recommended, given the very low incidence of this side effect. Additional studies are warranted to interpret our findings.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Future Sci OA
Year:
2021
Document Type:
Article
Affiliation country:
Fsoa-2021-0064
Similar
MEDLINE
...
LILACS
LIS